全文获取类型
收费全文 | 24068篇 |
免费 | 1946篇 |
国内免费 | 907篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 558篇 |
妇产科学 | 325篇 |
基础医学 | 2778篇 |
口腔科学 | 215篇 |
临床医学 | 1952篇 |
内科学 | 4643篇 |
皮肤病学 | 135篇 |
神经病学 | 1903篇 |
特种医学 | 721篇 |
外科学 | 1889篇 |
综合类 | 2927篇 |
现状与发展 | 3篇 |
预防医学 | 1641篇 |
眼科学 | 163篇 |
药学 | 4607篇 |
5篇 | |
中国医学 | 1436篇 |
肿瘤学 | 976篇 |
出版年
2023年 | 419篇 |
2022年 | 636篇 |
2021年 | 1051篇 |
2020年 | 842篇 |
2019年 | 719篇 |
2018年 | 739篇 |
2017年 | 722篇 |
2016年 | 807篇 |
2015年 | 835篇 |
2014年 | 1297篇 |
2013年 | 1689篇 |
2012年 | 1260篇 |
2011年 | 1222篇 |
2010年 | 1012篇 |
2009年 | 1000篇 |
2008年 | 999篇 |
2007年 | 992篇 |
2006年 | 868篇 |
2005年 | 806篇 |
2004年 | 671篇 |
2003年 | 597篇 |
2002年 | 525篇 |
2001年 | 527篇 |
2000年 | 438篇 |
1999年 | 385篇 |
1998年 | 334篇 |
1997年 | 367篇 |
1996年 | 335篇 |
1995年 | 319篇 |
1994年 | 317篇 |
1993年 | 298篇 |
1992年 | 296篇 |
1991年 | 283篇 |
1990年 | 255篇 |
1989年 | 225篇 |
1988年 | 237篇 |
1987年 | 227篇 |
1986年 | 197篇 |
1985年 | 245篇 |
1984年 | 281篇 |
1983年 | 149篇 |
1982年 | 201篇 |
1981年 | 162篇 |
1980年 | 159篇 |
1979年 | 159篇 |
1978年 | 131篇 |
1977年 | 118篇 |
1976年 | 118篇 |
1975年 | 91篇 |
1973年 | 74篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Khema R. Sharma Jane Kent-Braun Mark A. Mynhier Michael W. Weiner Robert G. Miller 《Muscle & nerve》1995,18(12):1403-1411
The goals of this study were to investigate muscle fatigue in patients with multiple sclerosis (MS), and to determine the relationships between muscle fatigue, clinical status, and perceived fatigue. The fatigability of the anterior tibial muscle was quantitated in patients and controls during 9 min of intermittent stimulation (used to eliminate central sources of muscle fatigue). During exercise, the decline in tetanic force, phosphocreatine, and intracellular pH was greater in patients than in controls. The compound muscle action potential amplitude did not decrease during exercise, indicating that there was no failure of neuromuscular transmission during fatigue. Thus, the excessive fatigue in MS developed from sources beyond the muscle membrane. Following exercise, the recovery of tetanic force was delayed in patients (a pattern that suggests abnormal excitation–contraction coupling), whereas the recovery of metabolites was complete in both groups. Muscular fatigue was correlated with clinical disability but not with perceived fatigue. These results suggests that fatigue in MS has both central (perception, upper motor neuron dysfunction) and peripheral (impaired metabolism and excitation–contraction coupling) components.© 1995 John Wiley &Sons, Inc. 相似文献
42.
HELEN J. GILL JAMES L. MAGGS STEPHEN MADDEN MUNIR PIRMOHAMED & B. KEVIN PARK 《British journal of clinical pharmacology》1996,42(3):347-353
1 Cytochrome P450-mediated bioactivation of sulphamethoxazole to a hydroxylamine has been implicated in the hypersensitivity reactions associated with co-trimoxazole administration. Inhibiting the formation of the hydroxylamine may be one method of preventing the high frequency of toxicity which is observed in HIV-infected patients. Therefore, in this study, we have investigated the ability of fluconazole and ketoconazole, known cytochrome P450 inhibitors, to inhibit the formation of sulphamethoxazole hydroxylamine.
2 Ten healthy male volunteers were given co-trimoxazole (800 mg sulphamethoxazole and 160 mg trimethoprim) alone or 1 h after either fluconazole (150 mg) or ketoconazole (200 mg) in a randomized fashion with a washout period of at least 1 week between each phase. Urine was collected for 24 h, and sulphamethoxazole and its metabolites were quantified by electrospray LC-MS.
3 Ketoconazole had no effect on the urinary recovery of sulphamethoxazole or any of its metabolites. In contrast, fluconazole significantly ( P <0.001) inhibited the formation of sulphamethoxazole hydroxylamine by 50.0±15.1%. Fluconazole also inhibited the oxidation of sulphamethoxazole to the 5-methylhydroxy and 5-methylhydroxy acetate metabolites by 69.9±15.8% and 64.0±12.0%, respectively, but had no effect on the amount of sulphamethoxazole, N4 -acetyl sulphamethoxazole, or sulphamethoxazole N1 -glucuronide excreted in urine.
4 The potential clinical benefit of using fluconazole to prevent hypersensitivity to co-trimoxazole in patients with AIDS needs to be assessed in a prospective study using both metabolite formation and the clinical occurrence of adverse reactions as end-points. 相似文献
2 Ten healthy male volunteers were given co-trimoxazole (800 mg sulphamethoxazole and 160 mg trimethoprim) alone or 1 h after either fluconazole (150 mg) or ketoconazole (200 mg) in a randomized fashion with a washout period of at least 1 week between each phase. Urine was collected for 24 h, and sulphamethoxazole and its metabolites were quantified by electrospray LC-MS.
3 Ketoconazole had no effect on the urinary recovery of sulphamethoxazole or any of its metabolites. In contrast, fluconazole significantly ( P <0.001) inhibited the formation of sulphamethoxazole hydroxylamine by 50.0±15.1%. Fluconazole also inhibited the oxidation of sulphamethoxazole to the 5-methylhydroxy and 5-methylhydroxy acetate metabolites by 69.9±15.8% and 64.0±12.0%, respectively, but had no effect on the amount of sulphamethoxazole, N
4 The potential clinical benefit of using fluconazole to prevent hypersensitivity to co-trimoxazole in patients with AIDS needs to be assessed in a prospective study using both metabolite formation and the clinical occurrence of adverse reactions as end-points. 相似文献
43.
在动物实验的基础上,比较了抗AFP单克隆抗体(mAb)和抗AFP多克隆抗体(pAb)两种不同抗体双弹头标记物在肝癌患者体内的生物代谢情况。结果显示,两种抗体标记物的血浆清除半衰期均在24h左右,mAb标记物的清除较pAb标记物略慢。尿清除的半衰期,mAb标记物约为120h,而pAb标记物则约为18h,表明二者的体内生物代谢不同,疗效可能不一。 相似文献
44.
Dario Roccatello Marco Formica Guido Cavalli Maria C. Amprimo Maria G. Pignatelli Paolo Costa Ruggero de Paulis Giacomo Quattrocchio rea Molino Gianbeppe Giordano 《Artificial organs》1990,14(1):69-72
Neutrophil oxidative metabolism, C3d and beta 2 microglobulin levels, were assessed in nine consecutive patients undergoing cardiopulmonary bypass surgery with polypropylene hollow fiber oxygenators for open cardiac operations. Generation of oxygen free radicals by neutrophils was measured as luminol-enhanced chemiluminescence after stimulation with opsonized Zymosan and phorbol myristate acetate. A significant increase in light emission was detected by using both of the chemiluminescence stimulators. Moreover, a remarkable and significant increase in C3d levels was found already at 10 min. Conversely minimal changes in levels of beta 2 microglobulin were detected during cardiopulmonary bypass surgery. These data suggest that the impact of the patient blood with the foreign surface of cardiopulmonary bypass results in activation of phagocyte cells with increased potential in oxygen consumption. These effects could be partially complement-mediated. 相似文献
45.
报道对链脲佐菌素(STZ)诱导的实验性糖尿病大鼠几种重要脏器(肝、肾、心、脑)卵磷脂、脑磷脂中脂肪酸构成的变化。不饱和脂肪酸变化的模式(C18:2n-6,C20:3n-6,C22:5n-3,C22:6n-3增加,C20:4n-6降低)基本相同,改变的先后顺序是肝→心、肾→脑。 相似文献
46.
47.
48.
B. A. Reikhardt L. M. Belyavtseva O. G. Kulikova 《Bulletin of experimental biology and medicine》1992,113(5):682-684
Academician S. V. Anichkov Department of Pharmacology, Research Institute of Experimental Medicine, Academy of Medical Sciences, St. Petersburg. (Presented by Academician of the Academy of Medical Sciences A. N. Klimov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 113, No. 5, pp. 506–508, May, 1992. 相似文献
49.
P. Jakobsson L. Jorfeldtt H. von Schenck 《Clinical physiology and functional imaging》1995,15(4):319-329
Summary. In order to investigate fat metabolism and the regulation of lipolysis and blood fuel metabolites by insulin, nine patients with chronic obstructive pulmonary disease (COPD) with chronic hypoxaemia and seven healthy control subjects of similar age were investigated by determination of the turnover rate of free fatty acids (TOR), using 1-14C-oleic acid as a tracer, and arterial concentrations of FFA, glycerol and 3-hydroxybutyrate. The measurements were performed in the basal state and during insulin and glucose infusion, aiming at euglycaemia at insulin levels of 50 and 100 mU l-1. The subjects' ages were 64±2.7 and 66±1.1 (mean±SEM) years in the COPD and control groups, respectively. TOR was 0.73±0.06 and 0.52±0.02 mmol min-1 (P<0.05) in the basal state, 0.33±0.04 and 0.30±0.02 at an insulin level of 50 mU I-1 and 0.32±0.08 and 0.24±0.02 at an insulin level of 100 mU I-1, in the COPD and control groups, respectively. Arterial FFA concentration was 0.98±0.08 and 0.75±0.06 mmol 1-1 (P<0.05) in the basal state in the COPD and control groups, respectively. During the clamp, the decrease in FFA mirrored that in TOR. The results show that the state of lipolysis is increased in severe COPD patients with chronic hypoxaemia. Furthermore, the results suggest a reduced effect of insulin in lipolysis. 相似文献
50.
Paul Saenger Kenneth M. Attie Joan DiMartino-Nardi Richard N. Fine 《Pediatric nephrology (Berlin, Germany)》1996,10(3):261-263
Carbohydrate metabolism was evaluated by fasting and postprandial glucose, insulin, and hemoglobin (Hb)A1c levels in children with chronic renal insufficiency and various other growth disorders treated with growth hormone. Mean fasting and postprandial glucose remained unchanged throughout the 5-year study period in all four study groups. Median fasting insulin levels rose from lownormal levels into the normal range after 5 years of growth hormone. Average fasting insulin level after 5 years was 10 mU/l. Median postprandial insulin values also rose, yet remained within the normal range at the 5-year mark. Mean Hb A1c levels remained within low to middle end of the normal range in the patients with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Mean Hb A1c levels at the 5 years were slightly elevated to 6.3% for the patients with chronic renal insufficiency. 相似文献